What is Viral Transport Kit Market?
The Viral Transport Kit is used to transport and preserve human nasopharyngeal or oropharyngeal virus samples from the collection site to the testing laboratory. The Kit also enables the safe transfer of viruses, chlamydia, and mycoplasma for further research, such as traditional cell culture methods, diagnostic tests, and molecular biology techniques. Virus samples, particularly RNA virus samples, degrade unless stored in an ultra-low temperature freezer or liquid nitrogen. However, due to their large size, weight, and, in the case of freezers, high energy consumption, such cooling equipment is rarely available in the field.
The market study is being classified by Type (Tissue Culture Medium and Glycerol Transport Medium), by Application (Herpes Simplex Type I, Herpes Simplex Type II, Cytomegalovirus (CMV), Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Echovirus, Adenovirus and Others) and major geographies with country level break-up.
Thermo Fisher Scientific (United States), Becton Dickinson (United States), Roche Holding AG (Switzerland), Merck & Co Inc (United States), EKF Diagnostics (United Kingdom), BioSpace (United States), Copan Diagnostics (United States), Trinity Biotech (Ireland), Sterilab Services (United Kingdom) and Titan Biotech (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are HiMedia (India), Hardy Diagnostics (United States) and Puritan Medical Products (United States).
The demand for Viral Transport Kits is increasing. Businesses in this sector face global competition from market leaders who control a large share of the market. Companies are differentiating their products from competition by employing environmentally friendly materials and manufacturing techniques. The Leading Players are engaging in strategic global expansion to maintain their Market Position. Players are expected to focus on the creation of new compounds, which would likely drive the worldwide market forward over the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Viral Transport Kit market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Viral Transport Kit market by Type, Application and Region.
On the basis of geography, the market of Viral Transport Kit has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Advent of Antigen Testing and Molecular Assay Experiments
- Increased Demand due to Coronavirus Pandemic
Market Trend
- Rising Prevalence of 3D Printed Swabs
Restraints
- High Cost of Viral Transport Kits
Opportunities
- Increased Government Initiatives for Infectious and Non-infectious Diseases
- Growing Geriatric Population
Challenges
- Growing Issue of False Negatives and Reinfection in COVID-19 Diagnosis
In October 2020 Thermo Fisher Scientific had announced the commissioning of a new facility in Perth, Scotland, that will greatly increase capacity for specialised sample collection products. The company will be able to boost manufacturing in Perth to over 8 million filled tubes per week thanks to the enhanced capacity and efficiencies. This is on top of Thermo Fisher's new production facility in Lenexa, Kansas, which produces 8 million tubes every week.
Key Target Audience
Venture and Capitalist, New entrants/investors, Analysts and Strategic Business Partners, Hospitals, Clinics and End-use industries